CKD-383
- Generic Name
- CKD-383
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 30
- Registration Number
- NCT06695572
- Locations
- π°π·
Bumin Hospital, Gangseo-gu, Seoul, Korea, Republic of
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 30
- Registration Number
- NCT06695598
- Locations
- π°π·
Bumin Hospital, Gangseo-gu, Seoul, Korea, Republic of
Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 30
- Registration Number
- NCT05897216
- Locations
- π°π·
CHA Bundang Medical Center, CHA University, Seongnam-si, Bundang, Korea, Republic of
Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 32
- Registration Number
- NCT05816759
- Locations
- π°π·
CHA Bundang Medical Center, CHA University, Seongnam-si, Bundang, Korea, Republic of
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
Phase 1
Completed
- Conditions
- Type2 Diabetes Mellitus
- Interventions
- Drug: CKD-501, D745, D150
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 27
- Registration Number
- NCT04810676
- Locations
- π°π·
Severance Hospital, Seoul, Yonsei-ro, Seodaemun-gu 50-1, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath